SJM
16
-3
OXY
55
6
EXPE
96
-3
JBHT
63
-5
MMM
42
5
CHD
48
-3
PFG
50
-2
AMAT
43
-5
QCOM
55
-2
C
62
-3
XEL
65
-2
DOV
73
4
FTI
78
-3
EMN
50
-2
GOOG
69
-10
GILD
56
-4
ABT
57
-5
SLG
62
-4
EXR
59
4
CNP
50
-2
SJM
16
-3
OXY
55
6
EXPE
96
-3
JBHT
63
-5
MMM
42
5
CHD
48
-3
PFG
50
-2
AMAT
43
-5
QCOM
55
-2
C
62
-3
XEL
65
-2
DOV
73
4
FTI
78
-3
EMN
50
-2
GOOG
69
-10
GILD
56
-4
ABT
57
-5
SLG
62
-4
EXR
59
4
CNP
50
-2
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
81

CORT
Corcept Therapeutics

Last Price:
54.76
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Corcept Therapeutics Price Quote

$54.76
-1.67 (-2.96%)
(Updated: November 14, 2024 at 5:55 PM ET)

Corcept Therapeutics Key Stats

Buy
81
Corcept Therapeutics (CORT) is a Buy
Day range:
$56.43 - $59.26
52-week range:
$20.84 - $61.66
Dividend yield:
0%
P/E ratio:
61.48
P/S ratio:
10.24
P/B ratio:
9.48%
Volume:
579.6K
Avg. volume:
1.1M
1-year change:
127.36%
Market cap:
$6.1B
Revenue:
$482.4M
EPS:
$1.26

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.46%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $144.7M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$23M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$96.1M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 25.77%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 21.04%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 25.77%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

Corcept Therapeutics Dividend Yield

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 46.43% 41.38%
Revenue: 47.69% 6.15%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 74.90
Upside from Last Price: 32.73%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    132.6M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.5M CORT shares are owned by insiders